141 related articles for article (PubMed ID: 24949437)
1. Pathway bridge based multiobjective optimization approach for lurking pathway prediction.
Zhang R; Zhao C; Xiong Z; Zhou X
Biomed Res Int; 2014; 2014():351095. PubMed ID: 24949437
[TBL] [Abstract][Full Text] [Related]
2. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X
Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005
[TBL] [Abstract][Full Text] [Related]
3. Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma.
Hong J; Shiba-Ishii A; Kim Y; Noguchi M; Sakamoto N
Cancer Sci; 2021 Dec; 112(12):5114-5126. PubMed ID: 34628698
[TBL] [Abstract][Full Text] [Related]
4. Cashmere growth control in Liaoning cashmere goat by ovarian carcinoma immunoreactive antigen-like protein 2 and decorin genes.
Jin M; Zhang JY; Chu MX; Piao J; Piao JA; Zhao FQ
Asian-Australas J Anim Sci; 2018 May; 31(5):650-657. PubMed ID: 29514440
[TBL] [Abstract][Full Text] [Related]
5. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
[TBL] [Abstract][Full Text] [Related]
6. A double helical motif in OCIAD2 is essential for its localization, interactions and STAT3 activation.
Sinha S; Bheemsetty VA; Inamdar MS
Sci Rep; 2018 May; 8(1):7362. PubMed ID: 29743632
[TBL] [Abstract][Full Text] [Related]
7. Ovarian carcinoma immunoreactive antigen-like protein 2 (OCIAD2) is a novel complex III-specific assembly factor in mitochondria.
Chojnacka KJ; Elancheliyan P; Mussulini BHM; Mohanraj K; Callegari S; Gosk A; Banach T; Góral T; Szczepanowska K; Rehling P; Serwa RA; Chacinska A
Mol Biol Cell; 2022 Apr; 33(4):ar29. PubMed ID: 35080992
[TBL] [Abstract][Full Text] [Related]
8. ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer.
Kennedy BA; Deatherage DE; Gu F; Tang B; Chan MW; Nephew KP; Huang TH; Jin VX
PLoS One; 2011; 6(7):e22606. PubMed ID: 21799915
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of OCIA domain containing 2 during stepwise progression of ovarian mucinous tumor.
Nagata C; Kobayashi H; Sakata A; Satomi K; Minami Y; Morishita Y; Ohara R; Yoshikawa H; Arai Y; Nishida M; Noguchi M
Pathol Int; 2012 Jul; 62(7):471-6. PubMed ID: 22726067
[TBL] [Abstract][Full Text] [Related]
11. High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.
Sakashita M; Sakashita S; Murata Y; Shiba-Ishii A; Kim Y; Matsuoka R; Nakano N; Sato Y; Noguchi M
Pathol Int; 2018 Nov; 68(11):596-604. PubMed ID: 30320419
[TBL] [Abstract][Full Text] [Related]
12. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
13. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
14. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation.
Cui J; Miner BM; Eldredge JB; Warrenfeltz SW; Dam P; Xu Y; Puett D
BMC Cancer; 2011 Jun; 11():280. PubMed ID: 21711548
[TBL] [Abstract][Full Text] [Related]
16. TGFβ Controls Ovarian Cancer Cell Proliferation.
Alsina-Sanchís E; Figueras A; Lahiguera A; Gil-Martín M; Pardo B; Piulats JM; Martí L; Ponce J; Matias-Guiu X; Vidal A; Villanueva A; Viñals F
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758950
[TBL] [Abstract][Full Text] [Related]
17. OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.
Ishiyama T; Kano J; Anami Y; Onuki T; Iijima T; Morisita Y; Yokota J; Noguchi M
Cancer Sci; 2007 Jan; 98(1):50-7. PubMed ID: 17054434
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.
Hurteau JA; Allison B; Sutton GP; Moore DH; Look KY; Hurd W; Bigsby RM
Cancer; 1999 Apr; 85(8):1810-5. PubMed ID: 10223576
[TBL] [Abstract][Full Text] [Related]
19. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.
Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
[TBL] [Abstract][Full Text] [Related]
20. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
